Molecular mechanisms of action of anti-TNF-α agents – Comparison among therapeutic TNF-α antagonists - ScienceDirect
In vitro Cell-Based Assays for Potency Testing of Anti-TNF-α Biological Drugs | IntechOpen
TNF Inhibitor - an overview | ScienceDirect Topics
Clinical Benefits of Switching from Original Infliximab to its Biosimilar (CT-P13) as a Potential TNF-α Inhibitor
The Role of Infliximab Biosimilar CT-P13 in Inflammatory Bowel Disease
Frontiers | Targeting TNF-α for COVID-19: Recent Advanced and Controversies
Treatment of Rheumatoid Arthritis with Biological Agents | IntechOpen
Mechanism of Action, Pharmacokinetics, and Drug Interactions of Etanercept in Dermatology - Kim A. Papp, Edward C. Keystone, Neil H. Shear, 2007
Novel therapeutic targets in rheumatoid arthritis: Trends in Pharmacological Sciences
Tuberculosis in the era of anti-TNF-alpha therapy: Why does the risk still exist?
Anti-TNF and skin inflammation in IBD: a new paradox in gastroenterology? | Gut
How does infliximab work in rheumatoid arthritis? | Arthritis Research & Therapy | Full Text
Frontiers | Use of TNF Inhibitors in Rheumatoid Arthritis and Implications for the Periodontal Status: For the Benefit of Both?
Emerging Mechanisms of Action and Loss of Response to Infliximab in Ibd: A Broader Picture
IJMS | Free Full-Text | Bimodal Function of Anti-TNF Treatment: Shall We Be Concerned about Anti-TNF Treatment in Patients with Rheumatoid Arthritis and Heart Failure?
New Drugs for Rheumatoid Arthritis | NEJM
IJMS | Free Full-Text | Pharmacogenomics of Anti-TNF Treatment Response Marks a New Era of Tailored Rheumatoid Arthritis Therapy
Genetic and genomic markers of anti-TNF treatment response in rheumatoid arthritis | Biomarkers in Medicine
GIH Exam 1 Pharmacology - Small and Large Bowel Drugs (Wallace) Flashcards | Quizlet
Anti-TNF-α therapies: the next generation | Nature Reviews Drug Discovery
Current immunotherapy in rheumatoid arthritis | Immunotherapy
